for Gene Therapy Development
À¯ÀüÀÚ¼¼Æ÷Ä¡·áÁ¦ÀÇ ½Å¼ÓÇÑ °³¹ß ¹× Á¦Á¶ ±×¸®°í »ó¾÷ȸ¦ À§Çؼ´Â ¸ñÀû¿¡ ¸Â´ÂWorkflows¸¦ °®Ãß´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ Virus vector ¹× Cell populations µî °íÇ°Áú Ä¡·áÁ¦ÀÇ È¿À²ÀûÀÎ »ý»ê¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃÅ°±â À§ÇÑ Instrumentµéµµ ÇÊ¿äÇÕ´Ï´Ù. ÇÏÁö¸¸ ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃÅ°±â À§ÇÑ Workflows´Â º¹ÀâÇϱ⠶§¹®¿¡ ¿¬±¸¿¡¼ ÀÓ»óÀ¸·Î ³Ñ¾î°¥ ¶§ Å« Çãµé·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ°ÍÀÇ ´ë¾ÈÀ¸·Î Bio-Techne¿¡¼ Á¦½ÃÇÕ´Ï´Ù!
Capillary Electrophoresis
ImmunoassayÀÎ Simple WesternÀº °³¹ß Àü¹Ý¿¡ °ÉÃÄ ÀÌ º¹ÀâÇÑ Workflows¸¦ °£¼ÒÈÇÏ´Â ¼Ö·ç¼ÇÀÔ´Ï´Ù.
ÀÌ Webinar¸¦ ÅëÇØ Simple WesternÀÇ ³ôÀº ÀçÇö¼º°ú ¿ÏÀü ÀÚµ¿È ±×¸®°í high-throughput Çü½ÄÀ¸·Î ´Ü¹éÁúÀ» Á¤·®È¿¡ ´ëÇØ ¾È³»Çϸç, ±×°ÍÀ»
°¡´ÉÇÏ°Ô Çϵµ·Ï µµ¿ÍÁÝ´Ï´Ù.
ƯÈ÷, Simple WesternÀº Virus
vector purity, identity, stability, ±×¸®°í
potency¸¦ Æ÷ÇÔÇÑ ¸î °¡Áö Critical Quality Attributes (CQAs)¿¡ ´ëÇÑ ½Ã°£À» ´ëÆø ´ÜÃà ½Ãų ¼ö ÀÖ½À´Ï´Ù.
À§ ¿þºñ³ª¸¦ ÅëÇØ À¯ÀüÀÚ¼¼Æ÷Ä¡·áÁ¦ÀÇ °³¹ß°ú ÀÓ»ó ½ÃÇè ¹× Á¦Á¶ Àü¹Ý¿¡ °ÉÄ£ Simple Western ApplicationÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
Áö±Ý ¹Ù·Î Âü°¡Çغ¸¼¼¿ä!
|